Nuclear Factor of Activated T Cells c1 Induces Osteoclast-associated Receptor Gene Expression during Tumor Necrosis Factor-related Activation-induced Cytokine-mediated Osteoclastogenesis-Reference-Cited by-同舟云学术

Nuclear Factor of Activated T Cells c1 Induces Osteoclast-associated Receptor Gene Expression during Tumor Necrosis Factor-related Activation-induced Cytokine-mediated Osteoclastogenesis

Published:2005-10 Issue:42 Volume:280 Page:35209-35216
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Kim Kabsun,Kim Jung Ha,Lee Junwon,Jin Hye-Mi,Lee Seoung-Hoon,Fisher David E.,Kook Hyun,Kim Kyung Keun,Choi Yongwon,Kim Nacksung

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference32 articles.

1. Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families

2. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

3. Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation

4. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts

5. Osteoclast differentiation and activation

Cited by 210 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanosensing by Piezo1 regulates osteoclast differentiation via PP2A-Akt axis in periodontitis;2024-09-05

2. Active fraction of Polyrhachis vicina (Rogers) inhibits osteoclastogenesis by targeting Trim38 mediated proteasomal degradation of TRAF6;Phytomedicine;2024-09

3. Smoking and osteoimmunology: Understanding the interplay between bone metabolism and immune homeostasis;Journal of Orthopaedic Translation;2024-05

4. Estradiol induces bone osteolysis in triple–negative breast cancer via its membrane–associated receptor ERα36;JBMR Plus;2024-03-26

5. Harnessing osteoimmunity to treat peri-implant inflammatory osteolysis;Materials Advances;2024